iGene, Vaccine/Diagnostic Reagents/Quarantine (Novel Flu, AI, etc.) Theme Rises 21.19% ↑

On the 5th, the vaccine/diagnostic reagent/epidemic prevention (including novel influenza, AI, etc.) theme rose 3.30% compared to the previous day, showing strength, while IGEN, a related stock drawing attention, surged 21.19% compared to the previous day. IGEN is known as a biopharmaceutical development company.

[Graph] Major stock price changes in the vaccine/diagnostic reagent/epidemic prevention (novel influenza, AI, etc.) theme



According to the analysis by Thinkpool Robo Algorithm RASSI, IGEN's quant financial score is 7.14 points, which is lower in stability, profitability, and growth scores compared to the average of other stocks related to the vaccine/diagnostic reagent/epidemic prevention (novel influenza, AI, etc.) theme. This can be interpreted as IGEN having relatively low investment attractiveness compared to other stocks from a financial perspective. On the other hand, Kolmar Holdings ranked first in quant financial ranking with higher growth, stability, and profitability scores compared to the average of other stocks.

[Table] Top stocks by financial score within the theme


※ The quant financial score is the result of the Robo Algorithm analyzing each company's sales growth rate, equity growth rate, debt ratio, current ratio, ROA, ROE, etc.

※ This article was generated in real time by an article automatic generation algorithm jointly developed by Asia Economy and the financial AI specialist Thinkpool.

This content was produced with the assistance of AI translation services.